Page last updated: 2024-08-23

sufentanil and Crohn Disease

sufentanil has been researched along with Crohn Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Hoore, A; Fieuws, S; Penninckx, F; Wolthuis, AM1
Colombel, JF; Desreumaux, P; Fleyfel, M; Gambiez, L; Guidat, A; Levron, JC; Scherpereel, P; Vallet, B1

Trials

1 trial(s) available for sufentanil and Crohn Disease

ArticleYear
Inflammation increases sufentanil requirements during surgery for inflammatory bowel diseases.
    European journal of anaesthesiology, 2003, Volume: 20, Issue:12

    Topics: Adult; Analgesics, Opioid; Analysis of Variance; Area Under Curve; Blood Sedimentation; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Female; Glycoproteins; Humans; Inflammation; Male; Prospective Studies; Reference Values; Sufentanil; Time Factors

2003

Other Studies

1 other study(ies) available for sufentanil and Crohn Disease

ArticleYear
Outcomes for case-matched single-port colectomy are comparable with conventional laparoscopic colectomy.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2012, Volume: 14, Issue:5

    Topics: Adenoma; Adult; Aged; Analgesics; Blood Loss, Surgical; Bupivacaine; C-Reactive Protein; Colectomy; Colonic Neoplasms; Crohn Disease; Diverticulitis, Colonic; Female; Humans; Laparoscopy; Length of Stay; Levobupivacaine; Male; Middle Aged; Pain, Postoperative; Statistics, Nonparametric; Sufentanil; Time Factors; Treatment Outcome

2012